A Meta-Analysis of the Results of Clinical Studies on the Efficacy and Tolerability of L-Lysine Aescinat in the Treatment of Traumatic Brain Injury and Acute Cerebrovascular Diseases
DOI:
https://doi.org/10.22141/2224-0713.6.76.2015.78073Keywords:
traumatic brain injury, treatment, basic therapy, L-Lysine AescinatAbstract
The article deals with the treatment of patients with traumatic brain injury and acute cerebrovascular accidents. A meta-analysis of clinical studies on the efficacy and safety of L-Lysine Aescinat in these patients is provided. The meta-analysis included results of 12 studies involving 1,728 patients of all age groups, of which 727 persons received L-Lysine Aescinat, solution for injection, in addition to the basic therapy. The following parameters were evaluated: changes in intracranial pressure (ICP); changes by the NIHSS; changes according to Glasgow Coma Scale (GCS); Glasgow Outcome Scale; mortality. It has been found that in patients treated with L-Lysine Aescinat, ICP decreased by an average of 21.87 %, while in patients receiving basic therapy alone, this index decreased only by 6.63 %. Indicators of GCS in the group of L-Lysine Aescinat increased by 66.89 %, while in the group where only basic therapy was administered — by 40.61 %. NIHSS values decreased by 47.10 % when using L-Lysine Aescinat, and when receiving only basic treatment — by 30.15 %. In the group of L-Lysine Aescinat, mortality was 10.75 % less than in patients receiving basic therapy alone.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 L.A. Dziak, A.H. Sirko
This work is licensed under a Creative Commons Attribution 4.0 International License.